Newgenivf's Crypto Gains Offset by Solana Losses

Newgenivf Group, an IVF service provider listed on Nasdaq, disclosed its crypto transactions for 2025. The company bought 146,432 XRP tokens and sold them all before year-end, earning a net gain of $10,849 from the transactions.

This activity is separate from Newgenivf's core business and reflects a capital allocation strategy rather than operational revenue. The firm also traded Bitcoin, Ethereum, and Solana, with only Solana holdings remaining at year-end, showing a significant unrealized loss due to the asset's price drop.